Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Coleman, R
  • Apffelstaedt, J
  • Gordon, D
  • Major, Pierre
  • Mackey, J
  • Howell, A
  • Theriault, R
  • Yambros, Y
  • Chen, B
  • Reitsma, D

publication date

  • April 2001